Investing Ideas
/
Swedish Biotech Stocks

Swedish Biotech Stocks

Results

2 new

Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.

60 companies

Swedish Orphan Biovitrum

Market Cap: SEK 96.4b

An integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

SOBI

SEK 280.80

-4.2%

7.4%

Camurus

Market Cap: SEK 33.1b

A biopharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, and internationally.

CAMX

SEK 565.00

-4.4%

11.2%

Vitrolife

Market Cap: SEK 22.0b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

VITR

SEK 162.80

1.0%

-14.9%

Bonesupport Holding

Market Cap: SEK 20.8b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

BONEX

SEK 316.40

5.3%

34.9%

AddLife

Market Cap: SEK 18.1b

Provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries.

ALIF B

SEK 148.40

-1.1%

36.8%

BioArctic

Market Cap: SEK 15.5b

Develops biological drugs for patients with disorders of the central nervous system in Sweden.

BIOA B

SEK 175.50

-3.6%

-16.6%

BioGaia

Market Cap: SEK 11.0b

A healthcare company, provides probiotic products worldwide.

BIOG B

SEK 108.40

0.4%

-6.6%

Biotage

Market Cap: SEK 7.5b

Provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.

BIOT

SEK 94.00

-4.5%

-46.7%

Swedencare

Market Cap: SEK 5.9b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in Sweden, the United Kingdom, Rest of Europe, North America, Asia, and internationally.

SECARE

SEK 37.30

-3.9%

-41.6%

MedCap

Market Cap: SEK 5.3b

A private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout.

MCAP

SEK 350.50

0.4%

-14.9%

Flerie

Market Cap: SEK 3.3b

A venture capital firm specializing in early-stage investments.

FLERIE

SEK 42.30

-5.8%

n/a

BICO Group

Market Cap: SEK 2.1b

Operates as a bioconvergence company in North America, Europe, Asia, and internationally.

BICO

SEK 29.76

-10.8%

-34.6%

Devyser Diagnostics

Market Cap: SEK 1.6b

Develops, manufactures, and sells diagnostic kits and solutions for DNA testing within hereditary diseases, oncology, and post-transplantation monitoring in Sweden, rest of Europe, the Middle East, Africa, North and South America, and Asia.

DVYSR

SEK 96.00

-9.9%

-7.7%

Genovis AB (publ.)

Market Cap: SEK 1.2b

Develops and sells tools for the development of new treatment methods and diagnostics for customers in the pharmaceutical and research industries.

GENO

SEK 18.96

-1.0%

-47.6%

Xspray Pharma

Market Cap: SEK 1.1b

A pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden.

XSPRAY

SEK 28.90

-4.0%

-29.0%

Saniona

Market Cap: SEK 694.3m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of treatments for rare disease patients in Sweden, Germany, Denmark, the United Kingdom, and Mexico.

SANION

SEK 6.17

8.1%

237.2%

Magle Chemoswed Holding

Market Cap: SEK 553.9m

Operates as a contract development and manufacturing organization that serves pharmaceutical and medical device industry on a contract basis in Sweden.

MAGLE

SEK 27.00

-12.9%

-18.7%

Cinclus Pharma Holding

Market Cap: SEK 530.5m

A clinical stage pharmaceutical company, engages in the development of the drug candidate for the treatment of related diseases.

CINPHA

SEK 11.40

-4.4%

n/a

Orexo

Market Cap: SEK 498.9m

A specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, and internationally.

ORX

SEK 14.46

-6.3%

-10.2%

FluoGuide

Market Cap: SEK 483.5m

A clinical stage biotechnology company, focuses on developing drugs for surgical outcomes by making cancer fluorescent in Denmark.

FLUO

SEK 35.50

-6.6%

-28.0%

IRLAB Therapeutics

Market Cap: SEK 402.5m

IRLAB Therapeutics AB (publ) discovers and develops drugs for the treatment of Parkinson’s disease and other CNS disorders.

IRLAB A

SEK 7.76

11.2%

-48.1%

Oncopeptides

Market Cap: SEK 367.1m

A biotech company, engages in the research, development, and commercialization of targeted therapies for difficult-to-treat hematological diseases in the United States, Europe, and internationally.

ONCO

SEK 1.71

16.2%

-70.9%

Moberg Pharma

Market Cap: SEK 364.0m

A pharmaceutical company, develops and commercializes medical products primarily in Sweden.

MOB

SEK 7.80

-1.0%

-78.1%

Xbrane Biopharma

Market Cap: SEK 289.3m

A biotechnology company, engages in the development, manufacture, and sale of biosimilars.

XBRANE

SEK 0.19

-18.4%

-44.1%

Mendus

Market Cap: SEK 280.0m

A biopharmaceutical company, develops immunotherapies for the treatment of tumor recurrence and established tumors.

IMMU

SEK 5.56

-7.3%

-42.1%

Ascelia Pharma

Market Cap: SEK 256.6m

A biotech company, focuses on orphan oncology treatments in Sweden.

ACE

SEK 2.67

-7.3%

-70.0%

Karolinska Development

Market Cap: SEK 242.8m

A venture capital firm specializing in investments in growth capital, seed stage, and early stage companies.

KDEV

SEK 0.90

-8.8%

-41.2%

Corline Biomedical

Market Cap: SEK 219.4m

Develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications.

CLBIO

SEK 8.96

-8.6%

-24.7%

NextCell Pharma

Market Cap: SEK 203.9m

A biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden.

NXTCL

SEK 2.79

-7.0%

-9.7%

Alzinova

Market Cap: SEK 168.0m

A biopharmaceutical company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.

New

ALZ

SEK 1.88

-32.2%

1.8%

SenzaGen

Market Cap: SEK 142.8m

Provides non-animal tests for assessing a substance’s allergenicity.

SENZA

SEK 4.84

-4.2%

-20.7%

Vivesto

Market Cap: SEK 131.0m

Develops, produces, markets, and sells drugs in the field of human and veterinary oncology in Sweden.

VIVE

SEK 0.24

4.3%

-22.9%

Enorama Pharma

Market Cap: SEK 127.0m

A pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden.

New

ERMA

SEK 2.10

-7.5%

-19.2%

AroCell

Market Cap: SEK 122.6m

A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.

AROC

SEK 0.53

0.4%

48.2%

Toleranzia

Market Cap: SEK 115.7m

A biotechnology company, develops and commercializes drugs for the treatment of autoimmune orphan diseases.

TOL

SEK 0.43

-5.3%

-20.3%

Elicera Therapeutics

Market Cap: SEK 103.5m

A clinical stage immuno-oncology company, develops cell and gene therapies for immune-based cancer treatments in Sweden.

ELIC

SEK 2.95

31.1%

126.1%

Page 1 of 2